Skip to main content
GALECTIN THERAPEUTICS INC logo

GALECTIN THERAPEUTICS INC — Investor Relations & Filings

Ticker · GALT ISIN · US3632252025 LEI · 5299004HFYSAZM2ALW85 US Manufacturing
Filings indexed 1,091 across all filing types
Latest filing 2010-02-17 Regulatory Filings
Country US United States of America
Listing US GALT

About GALECTIN THERAPEUTICS INC

https://galectintherapeutics.com/

Galectin Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for fibrotic diseases, chronic liver disease, and cancer. The company's therapeutic approach centers on inhibiting the galectin-3 protein, which is implicated in various inflammatory, fibrotic, and malignant conditions. Its lead drug candidate, belapectin (GR-MD-02), is a proprietary carbohydrate-based drug designed to bind to and inhibit galectin-3. The primary development program for belapectin is focused on treating non-alcoholic steatohepatitis (MASH) with cirrhosis, a serious liver disease with no currently approved therapies.

Recent filings

Filing Released Lang Actions
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content includes details about an amendment to a securities purchase agreement, changes to the certificate of designation for preferred stock, and appointments to the board of directors. There are no financial statements or detailed financial data presented, but rather announcements of agreements and management changes. The key elements are the amendment agreement related to securities and the appointment of new board members. This fits the category of a regulatory filing announcing material events rather than a full financial report or earnings release. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2010-02-17 English
SC 13D/A Filing
Major Shareholding Notification
2010-02-09 English
SC 13D/A Filing
Major Shareholding Notification
2010-02-09 English
SC 13D/A Filing
Major Shareholding Notification
2010-02-09 English
4 Filing
Director's Dealing
2010-02-03 English
4 Filing
Director's Dealing
2010-02-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.